GILD, ROIV win FDA nod in weekly biotech buzz
Weekly Buzz highlights FDA nods for GILD and ROIV; also cites a BHVN/LLY deal and SYRE missing a monotherapy goal.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.